TrialRespiratory research2020

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.

Mirco Govoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.